Cogent Biosciences

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell COGT and other ETFs, options, and stocks.

About COGT

Cogent Biosciences, Inc. is a biotechnology company, which engages in the development of precision therapies for genetically defined diseases. It focuses on CGT9486, a selective tyrosine kinase inhibitor that is designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17.

CEO

Andrew R. Robbins

CEOAndrew R. Robbins

Employees

164

Employees164

Headquarters

Waltham, Massachusetts

HeadquartersWaltham, Massachusetts

Founded

2014

Founded2014

Employees

164

Employees164

COGT Key Statistics

Market cap

679.59M

Market cap679.59M

Price-Earnings ratio

-2.72

Price-Earnings ratio-2.72

Dividend yield

—

Dividend yield—

Average volume

1.37M

Average volume1.37M

High today

$7.12

High today$7.12

Low today

$6.54

Low today$6.54

Open price

$6.95

Open price$6.95

Volume

1.48M

Volume1.48M

52 Week high

$13.50

52 Week high$13.50

52 Week low

$3.67

52 Week low$3.67

Analyst ratings

82%

of 11 ratings

Buy

81.8%

Hold

18.2%

Sell